Pyrrolocarbazoles as checkpoint 1 kinase inhibitors

  • Hélène Hénon
  • , Elisabeth Conchon
  • , Bernadette Hugon
  • , Samir Messaoudi
  • , Roy M. Golsteyn
  • , Michelle Prudhomme

Research output: Contribution to journalReview articlepeer-review

Abstract

The carbazole framework is found in many natural compounds of biological interest. Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites. In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy. This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compounds bearing four or five fuse rings.

Original languageEnglish
Pages (from-to)577-597
Number of pages21
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume8
Issue number6
DOIs
Publication statusPublished - 1 Jan 2008
Externally publishedYes

Keywords

  • Antitumor agents
  • Checkpoint kinase 1
  • Granulatimide
  • Pyrrolocarbazole

Fingerprint

Dive into the research topics of 'Pyrrolocarbazoles as checkpoint 1 kinase inhibitors'. Together they form a unique fingerprint.

Cite this